← Evidence map

ReviewCurrent pharmaceutical design2025

Metabolic Targets in CRC: The Emerging Role of Cytochrome P450 Inhibitors.

Hawraa Ibrahim Alshakarchi et al.PubMed ↗Publisher ↗

No numbers read from the abstract.

Not cited yet

Full record →Abstract, authors, funding and every citing paper · PMID 40454501